| 51 |
[Papers] Rifaximin reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial
|
IIBR |
0 |
2021-09-13 |
|
| 50 |
[Papers] Antiobesity therapeutics with complementary dual-agonist activities at glucagon and glucagon-like peptide 1 receptors.
|
IIBR |
0 |
2021-09-06 |
|
| 49 |
[Papers]Transcriptome Analysis Identifies Altered Biological Processes and Novel Markers in Human Immunodeficiency Virus-1 Long-Term Non-Progressors
|
IIBR |
2 |
2021-09-01 |
|
| 48 |
[Papers] Aberrant activation of the CD45-Wnt signaling axis promotes stemness and therapy resistance in colorectal cancer cells
|
IIBR |
1 |
2021-08-11 |
|
| 47 |
[Papers] HiDRA: Hierarchical Network for Drug Response Prediction with Attention
|
IIBR |
1 |
2021-08-03 |
|
| 46 |
[Papers] The mechanism of gap creation by a multifunctional nuclease during base excision repair
|
IIBR |
0 |
2021-07-14 |
|
| 45 |
[Papers] Global Alternative Splicing Defects in Human Breast Cancer Cells
|
IIBR |
0 |
2021-06-20 |
|
| 44 |
[Papers] Genome-Wide Transcriptomic Analysis of Non-Tumorigenic Tissues Reveals Aging-Related Prognostic Markers and Drug Targets in Renal Cell Carcinoma
|
IIBR |
0 |
2021-06-18 |
|
| 43 |
[Papers]Testicular germ cell-specific lncRNA, Teshl, is required for complete expression of Y chromosome genes and a normal offspring sex ratio
|
IIBR |
0 |
2021-06-09 |
|
| 42 |
[Papers] NSrp70 is a lymphocyte-essential splicing factor that controls thymocyte development
|
IIBR |
1 |
2021-05-25 |
|
